Stay updated on Tepotinib Phase II Clinical Trial
Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.

Latest updates to the Tepotinib Phase II Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows recruitment is no longer open to participants. New guidance sections—How to Read a Study Record, Common Questions, and How to Join a Study—have been added to help users navigate and understand the record.SummaryDifference0.2%

- Check7 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a small build update without altering the study content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedFooter revision updated from v3.5.3 to v3.5.4, indicating a minor site update. No changes to the study details or page structure are evident.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page’s displayed software/content “Revision” label has been updated from v3.5.2 to v3.5.3, indicating a release/version change without altering the underlying study information.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded revisions dated 2026-04-13, 2026-03-23, and 2026-03 with Revision: v3.5.2, and removed revisions dated 2025-12-23, 2025-12-04, and 2025-12 with Revision: v3.5.0. The changes pertain to the site's revision history and do not affect the study page content.SummaryDifference0.1%

- Check71 days agoChange DetectedPadua, Italy was replaced with Padova, Italy in the study locations.SummaryDifference0.1%

Stay in the know with updates to Tepotinib Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.